Cargando…
High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
Autores principales: | Hsieh, Yu-Hsi, Lin, Hwai-Jeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588399/ https://www.ncbi.nlm.nih.gov/pubmed/23476639 http://dx.doi.org/10.1155/2013/803139 |
Ejemplares similares
-
Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
por: Yen, Hsu-Heng, et al.
Publicado: (2012) -
A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding
por: Lu, Lung-Sheng, et al.
Publicado: (2012) -
Oral Proton Pump Inhibitors May Be as Effective as Intravenous in Peptic Ulcer Bleeding: A Systematic Review and Meta-analysis
por: Csiki, Endre, et al.
Publicado: (2021) -
Comparison of Oral and Intravenous Proton Pump Inhibitor on Patients with High Risk Bleeding Peptic Ulcers: A Prospective, Randomized, Controlled Clinical Trial
por: Mostaghni, A A, et al.
Publicado: (2011) -
High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)